Novogene Overview
- Year Founded
-
2011
- Status
-
Public
- Employees
-
2,202
- Stock Symbol
-
688315
- Investments
-
3
- Share Price
-
$2.07
- (As of Friday Closing)
Novogene General Information
Description
Novogene Co Ltd is engaged in providing multi-level scientific research and technical services and solutions for life science basic research, medical and clinical application research, and independent development and innovation of genetic testing medical equipment.
Contact Information
Website
novogene.comCorporate Office
- Building 301, Zone A10 Jiuxianqiao North Road
- Chaoyang District
- Beijing
- China
Corporate Office
- Building 301, Zone A10 Jiuxianqiao North Road
- Chaoyang District
- Beijing
- China
Novogene Stock Performance
As of 11-Jul-2025, Novogene’s stock price is $2.07. Its current market cap is $862M with 416M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.07 | $2.08 | $1.28 - $2.91 | $862M | 416M | 4.76M | $0.07 |
Novogene Financials Summary
As of 31-Mar-2025, Novogene has a trailing 12-month revenue of $298M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 691,287 | 543,335 | 1,247,210 | 1,414,135 |
| Revenue | 297,682 | 294,242 | 282,988 | 285,934 |
| EBITDA | 31,388 | 52,826 | 50,421 | 50,706 |
| Net Income | 28,223 | 27,425 | 25,168 | 26,317 |
| Total Assets | 500,804 | 498,209 | 507,071 | 441,824 |
| Total Debt | 6,917 | 5,860 | 5,950 | 7,142 |
Novogene Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Novogene Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Novogene Comparisons
Industry
Financing
Details
Novogene Competitors (31)
One of Novogene’s 31 competitors is BGI Genomics, a Formerly VC-backed company based in Shenzhen, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BGI Genomics | Formerly VC-backed | Shenzhen, China | ||||
| Autogenomics | Formerly VC-backed | Carlsbad, CA | ||||
| Agendia | Venture Capital-Backed | Irvine, CA | ||||
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Qiagen | Formerly VC-backed | Venlo, Netherlands |
Novogene Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Novogene Patents
Novogene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| DE-112023002136-T5 | Method and apparatus for high-throughput production of omics products | Pending | 30-Sep-2022 |
Novogene Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Novogene Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Novogene Investments (3)
Novogene’s most recent deal was a Corporate Asset Purchase with PacBio (Portfolio of Revio Sequencers). The deal was made on 10-Jan-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| PacBio (Portfolio of Revio Sequencers) | 10-Jan-2024 | Corporate Asset Purchase | Buildings and Property | ||
| AiJiaZaoCha | 28-Sep-2016 | Early Stage VC | Laboratory Services (Healthcare) | ||
| NovogeneAIT Genomics Singapore | 07-Sep-2016 | Joint Venture | Laboratory Services (Healthcare) |
Novogene ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Services
Subindustry
Rank
Percentile
Novogene FAQs
-
When was Novogene founded?
Novogene was founded in 2011.
-
Where is Novogene headquartered?
Novogene is headquartered in Beijing, China.
-
What is the size of Novogene?
Novogene has 2,202 total employees.
-
What industry is Novogene in?
Novogene’s primary industry is Biotechnology.
-
Is Novogene a private or public company?
Novogene is a Public company.
-
What is Novogene’s stock symbol?
The ticker symbol for Novogene is 688315.
-
What is the current stock price of Novogene?
As of 11-Jul-2025 the stock price of Novogene is $2.07.
-
What is the current market cap of Novogene?
The current market capitalization of Novogene is $862M.
-
What is Novogene’s current revenue?
The trailing twelve month revenue for Novogene is $298M.
-
Who are Novogene’s competitors?
BGI Genomics, Autogenomics, Agendia, Illumina, and Qiagen are some of the 31 competitors of Novogene.
-
What is Novogene’s annual earnings per share (EPS)?
Novogene’s EPS for 12 months was $0.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
